Provided is a method for formulating an immunogenic composition for treating a melanoma cancer situated in a human patient's skin, comprising: producing an antigenic composition comprising a vaccinia virus; and, formulating the antigenic composition for administration as an immunogenic composition capable of eliciting an immune reaction to treat the melanoma cancer in the human patient. The medicament can be formulated for repeated subcutaneous or intradermal administration.